Reflecting on the Inaugural Artificial Intelligence in Oncology Symposium

Collage of speakers at AIO 2019

On October 24, the Case Comprehensive Cancer Center and the Center for Computational Imaging and Personalized Diagnostics hosted the inaugural Artificial Intelligence in Oncology Symposium on the campus of Case Western Reserve University. With the help of the planning committee, the event brought together experts in Artificial Intelligence (AI) and machine learning as well as clinical, industry and federal agency experts in pathology, radiology, oncology and immuno-oncology. In its first year, the symposium drew 270 registrants with 50 attendees tuning in to a livestream, representing 12 U.S. states and 8 countries. The response to this unique symposium was so successful that a 2020 event is already being planned.  

The symposium began with remarks from Barbara Snyder, Case Western Reserve University President, and Pamela B. Davis, MD, PhD, Dean of the Case Western Reserve University School of Medicine, who expressed excitement for this event and their support of the innovative AI research being conducted on our campus and through the Case Comprehensive Cancer Center.  

The day featured an impressive lineup of speakers, organized into four sessions and focused on developments and opportunities for AI in radiology, pathology & genomics, immuno-oncology, and policy & ethics. Each session was enhanced by a panel discussion where the invited speakers were joined by additional experts for lively dialogue in response to audience questions asked in person and via Twitter.

The keynote address, delivered by Sohrab Shah, PhD from Weill Cornell Medical College and Memorial Sloan Kettering Cancer Center, highlighted Shah's research on the use of computational methods to understand cancer evolution and treatment response. Invited speakers for the morning sessions on radiology, pathology & genomics included Hugo Aerts, PhD, Harvard Medical School and Program for Artificial Intelligence in Medicine at Brigham and Women’s Hospital; Brian Hobbs, PhD, Cleveland Clinic; Michael Feldman, PhD, University of Pennsylvania Healthcare System; and Kevin White, PhD, Tempus. The afternoon session on AI in immuno-oncology included invited speaker Michael Montalto, PhD, Bristol-Myers Squibb. The day wrapped up with a session on policy and ethical considerations for AI, during which participants heard from Brandon Gallas, PhD, Food and Drug Administration and Sharona Hoffman, JD, Case Western Reserve University School of Law.

Thank you to our participants, sponsors, speakers, panelists, moderators and planning committee for making this inaugural event a success. We look forward to seeing you at next year’s event to continue to learn and discuss the ways that AI is transforming the medical landscape for oncology in Cleveland’s unique ecosystem and beyond.

Anant Madabhushi, PhD, FAIMBE, FIEEE, FCoulter
Chair, Planning Committee, Artificial Intelligence in Oncology Symposium
F. Alex Nason Professor II
Director, Center for Computational Imaging & Personalized Diagnostics
Departments of Biomedical Engineering, Urology, Radiology, Pathology, Radiation Oncology, Electrical Engineering & Computer Sciences and General Medical Sciences
Member, Case Comprehensive Cancer Center
Case Western Reserve University

View symposium photos